CD47 and colorectal adenocarcinoma: Association between CD47 expression, clinical characteristics and prognosis in patients with different malignancies, including advanced non-small cell lung cancer [1], gastric cancer [2], colorectal adenocarcinoma [3] and pancreatic neuroendocrine tumor [4] has been explored.